Using Fidelity Measurement to Assess Quality of Early Psychosis Intervention Services in Ontario.


Journal

Psychiatric services (Washington, D.C.)
ISSN: 1557-9700
Titre abrégé: Psychiatr Serv
Pays: United States
ID NLM: 9502838

Informations de publication

Date de publication:
01 09 2019
Historique:
pubmed: 5 6 2019
medline: 7 7 2020
entrez: 5 6 2019
Statut: ppublish

Résumé

The First Episode Psychosis Services Fidelity Scale (FEPS-FS) is a validated measure of program delivery in relation to international standards. This study assessed fidelity in Ontario programs and the utility of the FEPS-FS for program improvement. Assessments were conducted in a volunteer sample of nine early psychosis intervention (EPI) programs. Thirty components of care were each rated on a 5-point scale; a rating of 4 indicates satisfactory performance. Trained assessor teams conducted site visits, and ratings were made by consensus. Program mean fidelity ratings ranged from 3.1 to 4.4 and exceeded 4 in five programs. Across the programs, item mean fidelity ratings ranged from 2.1 to 5 and exceeded 4 for 14 of 30 items. The FEPS-FS captured variation in program implementation and provided a baseline for measuring change. Additions to the scale are planned to address components of the Ontario EPI standards not covered by the FEPS-FS.

Identifiants

pubmed: 31159664
doi: 10.1176/appi.ps.201800581
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

840-844

Auteurs

Janet Durbin (J)

Centre for Addiction and Mental Health, Toronto (Durbin, Selick); Department of Psychiatry, University of Toronto, Toronto (Durbin); Haliburton Kawartha Pine Ridge Branch, Canadian Mental Health Association, Peterborough, Ontario (Langill); Psychiatry Section, Clinical Sciences, Northern Ontario School of Medicine, Thunder Bay, Ontario (Cheng); Department of Psychiatry and Behavioural Neuroscience, McMaster University, Hamilton, Ontario (Archie); Elgin Branch, Canadian Mental Health Association, St. Thomas, Ontario (Butt); Department of Psychiatry, University of Calgary, Calgary, Alberta (Addington).

Avra Selick (A)

Centre for Addiction and Mental Health, Toronto (Durbin, Selick); Department of Psychiatry, University of Toronto, Toronto (Durbin); Haliburton Kawartha Pine Ridge Branch, Canadian Mental Health Association, Peterborough, Ontario (Langill); Psychiatry Section, Clinical Sciences, Northern Ontario School of Medicine, Thunder Bay, Ontario (Cheng); Department of Psychiatry and Behavioural Neuroscience, McMaster University, Hamilton, Ontario (Archie); Elgin Branch, Canadian Mental Health Association, St. Thomas, Ontario (Butt); Department of Psychiatry, University of Calgary, Calgary, Alberta (Addington).

Gordon Langill (G)

Centre for Addiction and Mental Health, Toronto (Durbin, Selick); Department of Psychiatry, University of Toronto, Toronto (Durbin); Haliburton Kawartha Pine Ridge Branch, Canadian Mental Health Association, Peterborough, Ontario (Langill); Psychiatry Section, Clinical Sciences, Northern Ontario School of Medicine, Thunder Bay, Ontario (Cheng); Department of Psychiatry and Behavioural Neuroscience, McMaster University, Hamilton, Ontario (Archie); Elgin Branch, Canadian Mental Health Association, St. Thomas, Ontario (Butt); Department of Psychiatry, University of Calgary, Calgary, Alberta (Addington).

Chiachen Cheng (C)

Centre for Addiction and Mental Health, Toronto (Durbin, Selick); Department of Psychiatry, University of Toronto, Toronto (Durbin); Haliburton Kawartha Pine Ridge Branch, Canadian Mental Health Association, Peterborough, Ontario (Langill); Psychiatry Section, Clinical Sciences, Northern Ontario School of Medicine, Thunder Bay, Ontario (Cheng); Department of Psychiatry and Behavioural Neuroscience, McMaster University, Hamilton, Ontario (Archie); Elgin Branch, Canadian Mental Health Association, St. Thomas, Ontario (Butt); Department of Psychiatry, University of Calgary, Calgary, Alberta (Addington).

Suzanne Archie (S)

Centre for Addiction and Mental Health, Toronto (Durbin, Selick); Department of Psychiatry, University of Toronto, Toronto (Durbin); Haliburton Kawartha Pine Ridge Branch, Canadian Mental Health Association, Peterborough, Ontario (Langill); Psychiatry Section, Clinical Sciences, Northern Ontario School of Medicine, Thunder Bay, Ontario (Cheng); Department of Psychiatry and Behavioural Neuroscience, McMaster University, Hamilton, Ontario (Archie); Elgin Branch, Canadian Mental Health Association, St. Thomas, Ontario (Butt); Department of Psychiatry, University of Calgary, Calgary, Alberta (Addington).

Shannel Butt (S)

Centre for Addiction and Mental Health, Toronto (Durbin, Selick); Department of Psychiatry, University of Toronto, Toronto (Durbin); Haliburton Kawartha Pine Ridge Branch, Canadian Mental Health Association, Peterborough, Ontario (Langill); Psychiatry Section, Clinical Sciences, Northern Ontario School of Medicine, Thunder Bay, Ontario (Cheng); Department of Psychiatry and Behavioural Neuroscience, McMaster University, Hamilton, Ontario (Archie); Elgin Branch, Canadian Mental Health Association, St. Thomas, Ontario (Butt); Department of Psychiatry, University of Calgary, Calgary, Alberta (Addington).

Donald E Addington (DE)

Centre for Addiction and Mental Health, Toronto (Durbin, Selick); Department of Psychiatry, University of Toronto, Toronto (Durbin); Haliburton Kawartha Pine Ridge Branch, Canadian Mental Health Association, Peterborough, Ontario (Langill); Psychiatry Section, Clinical Sciences, Northern Ontario School of Medicine, Thunder Bay, Ontario (Cheng); Department of Psychiatry and Behavioural Neuroscience, McMaster University, Hamilton, Ontario (Archie); Elgin Branch, Canadian Mental Health Association, St. Thomas, Ontario (Butt); Department of Psychiatry, University of Calgary, Calgary, Alberta (Addington).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH